Stability of famotidine in commonly used nutritional infusion fluids. 1988

W J Underberg, and J M Koomen, and J H Beijnen

UI MeSH Term Description Entries
D010288 Parenteral Nutrition The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously). Intravenous Feeding,Nutrition, Parenteral,Parenteral Feeding,Feeding, Intravenous,Feeding, Parenteral,Feedings, Intravenous,Feedings, Parenteral,Intravenous Feedings,Parenteral Feedings
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D015738 Famotidine A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. Famotidine Hydrochloride,MK-208,Pepcid,YM-11170,MK 208,MK208,YM 11170,YM11170

Related Publications

W J Underberg, and J M Koomen, and J H Beijnen
November 1990, DICP : the annals of pharmacotherapy,
W J Underberg, and J M Koomen, and J H Beijnen
January 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
W J Underberg, and J M Koomen, and J H Beijnen
January 1991, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
W J Underberg, and J M Koomen, and J H Beijnen
July 1988, American journal of hospital pharmacy,
W J Underberg, and J M Koomen, and J H Beijnen
January 1992, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
W J Underberg, and J M Koomen, and J H Beijnen
May 2010, The Canadian journal of hospital pharmacy,
W J Underberg, and J M Koomen, and J H Beijnen
January 1991, Dermatologica,
W J Underberg, and J M Koomen, and J H Beijnen
October 1989, American journal of hospital pharmacy,
W J Underberg, and J M Koomen, and J H Beijnen
January 2017, Drug design, development and therapy,
W J Underberg, and J M Koomen, and J H Beijnen
December 2015, Current therapeutic research, clinical and experimental,
Copied contents to your clipboard!